Research on markers for omalizumab therapy in asthma

Research on markers for omalizumab therapy in asthma - Research on markers for omalizumab therapy in asthma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018619

Enrollment

Registered

2015-08-11

Start date

2013-06-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients planned to use omalizumab.

Exclusion criteria

Exclusion criteria: Patients without researcher's assent.

Design outcomes

Primary

Measure	Time frame
Relationship between clinical outcomes and biomarkers.	—

Countries

Japan

Contacts

Public ContactKenichi Konno

National Hospital Organization Tokyo National Hospital Clinical Research Center

fueta-tky@umin.ac.jp0424912111

Outcome results